Listed

Nuo Therapeutics, Inc.

AURXOTCCIK 1091596HealthcareFiscal year ends Dec 31

Reports and events: 271 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Nuo Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2022-04-1517:14 ET10-KAnnual reportPeriod 2021-12-310001437749-22-009050
2022-01-0412:16 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001437749-22-000240
2021-04-2108:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-21-009408
2020-10-0616:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001437749-20-020804
2020-04-1314:10 ET8-K8.01 Other events0001437749-20-007568
2020-03-3013:10 ET8-K8.01 Other events0001437749-20-006478
2020-01-3116:15 ET10-QQuarterly reportPeriod 2019-09-300001437749-20-001481
2019-12-1209:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001437749-19-024265
2019-11-2016:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001437749-19-023291
2019-08-1916:33 ET10-QQuarterly reportPeriod 2019-06-300001437749-19-017108
2019-08-0916:17 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-19-016241
2019-06-1316:22 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-19-011974
2019-05-2017:02 ET10-QQuarterly reportPeriod 2019-03-310001437749-19-010509
2019-05-0716:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-19-008997
2019-04-1617:27 ET10-KAnnual reportPeriod 2018-12-310001437749-19-007338
2019-03-2208:45 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-19-005473
2019-01-1517:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-19-000878
2019-01-0316:15 ET8-K5.02 Departure or appointment of officers or directors0001437749-19-000179
2018-11-1617:10 ET10-QQuarterly reportPeriod 2018-09-300001437749-18-021015
2018-10-2608:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-18-018842
2018-10-0217:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-18-017804
2018-09-2116:33 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001437749-18-017316
2018-09-0516:15 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-18-016613
2018-08-2808:33 ETDEF 14AProxy statementPeriod 2018-09-280001437749-18-016223
2018-08-1316:31 ET10-QQuarterly reportPeriod 2018-06-300001437749-18-015352
2018-08-1016:15 ET8-K4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-18-015225
2018-06-2815:54 ET8-K5.02 Departure or appointment of officers or directors0001437749-18-012607
2018-05-3017:19 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-18-010953
2018-05-1416:31 ET10-QQuarterly reportPeriod 2018-03-310001437749-18-009777
2018-04-1616:31 ET10-KAnnual reportPeriod 2017-12-310001437749-18-006937
2018-04-0417:15 ET8-K8.01 Other events0001437749-18-006341
2018-01-1916:35 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001437749-18-000852
2017-11-1317:17 ET10-QQuarterly reportPeriod 2017-09-300001437749-17-019152
2017-09-2817:00 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001437749-17-016478
2017-09-2115:49 ETSC 13D/AOwnership report, active investor, amended0001683168-17-002438
2017-09-1417:00 ET8-K3.02 Unregistered sale of equity; 8.01 Other events0001437749-17-015953
2017-08-2116:02 ETSC 13DOwnership report, active investor0001437749-17-015104
2017-08-1816:59 ETSC 13D/AOwnership report, active investor, amended0001193125-17-262319
2017-08-1417:04 ET8-K3.02 Unregistered sale of equity; 8.01 Other events0001437749-17-014747
2017-08-1418:50 ET10-QQuarterly reportPeriod 2017-06-300001437749-17-014570
2017-07-0517:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-17-012251
2017-06-3017:23 ETS-1/ARegistration statement, amended0001437749-17-012109
2017-06-2121:39 ETS-1/ARegistration statement, amended0001437749-17-011557
2017-06-1216:02 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-17-011132
2017-05-1516:11 ET10-QQuarterly reportPeriod 2017-03-310001437749-17-009226
2017-05-0816:52 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-17-008304
2017-04-2812:03 ETDEF 14AProxy statementPeriod 2017-04-280001437749-17-007397
2017-04-1106:14 ETS-1Registration statement0001437749-17-006388
2017-04-1007:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-17-006331
2017-03-2920:41 ET10-KAnnual reportPeriod 2016-12-310001437749-17-005460

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:44 ET. Listed shows no prices and gives no investment advice.